AzTrials
AzTrials

HaemodynamicsFacPPVNCT04802668

Factors Influencing of Pulse Pressure Variation (PPV)

An observational study of Haemodynamics and Fluid Responsiveness, run by Southeast University, China at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators studied the predictive value of PPV in the patients with different influencing factors;and the method to improve the predictive value,which can improve the application of PPV in ICU. Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
spontaneous breathing and no spontaneous breathing
How many people
189 participants
Where
1 siteChina
Study dates
20 Mar 2021to 30 Jul 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients with circulatory failure selected to enter the Department of Critical Care Medicine

Who may be able to join

  • Patients requiring invasive mechanical ventilation
  • Acute circulatory failure,defined as:systolic blood pressure <90 mmHg or blood pressure in patients with previous hypertension lower than the baseline value> 40 mmHg; vasoactive drugs are required to maintain blood pressure (mean arterial pressure> 65 mmHg); with or without signs of hypoperfusion (oliguria<0.5ml.kg-1.h-1 for at least 2 hours; arterial blood lactic acid>2.5mmol.L-1; skin mottling)

Who cannot join

  • The age of the patient is less than 18 years old or more than 80 years old
  • Refuse to sign the informed consent to join the group
  • Atrial fibrillation and other arrhythmias that seriously affect the output per beat;
  • With pregnancy
  • Other situations where the clinician believes that the patient is not suitable for inclusion in the study

Trial locations and contacts

1 site in 1 country.

China1 site
  • Ling Liu

    Nanjing, Jiangsu, 210009

Other trials in China

About this study

Official title: Factors Influencing the Reliability of Pulse Pressure Variation (PPV) as a Predictor of Fluid Responsiveness in Mechanically Ventilated Patients

The investigators studied the predictive value of PPV in the patients with different influencing factors;and the method to improve the predictive value,which can improve the application of PPV in ICU.

Read the detailed description

PPV can be used to predict fluid responsiveness in patients with circulatory shock.However, it is affected by many factors, which leads to the decrease of the applicability of PPV in ICU.Therefore, the investigators studied the predictive value of PPV in the patients with different influencing factors;and the method to improve the predictive value,which can improve the application of PPV in ICU.

Being tested
Patients were ventilated with assist-control ventilation(A/C) mode at different tidal volume, spontaneous breathing and no spontaneous breathing
Keywords
haemodynamics;, Pulse pressure variation;, fluid responsiveness;, Mechanical ventilation;

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patients were ventilated with assist-control ventilation(A/C) mode at different tidal volumeDevice

    Ventilation mode was set to assist-control volume ventilation with different tidal volume, respiratory frequency 15 times/min, PEEP 5 centimeter water column.

  • spontaneous breathing and no spontaneous breathingBehavioural

    Data were recorded when patients had and did not have spontaneous breathing

Study groups in NCT04802668
Study groupRoleWhat they receive
Circulatory failure patientsCirculatory failure patients requiring fluid responsiveness evaluation
Receives: Device: Patients were ventilated with assist-control ventilation(A/C) mode at different tidal volume; Behavioral: spontaneous breathing and no spontaneous breathing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. cardiac output(CO)

    The measurement of cardiac output(CO);

    Measured: 1 day

Secondary outcomes (5)
  1. measurement of Hemodynamic variables from the monitor;

    The investigators record the hemodynamic variables from the monitor MAP and CVP

    Measured: 1 day

  2. measurement of Pulse pressure variation(PPV)from monitor;

    Pulse pressure variation (PPV)(percent) ,whic is calculated from the systolic and diastolic blood pressure,can be read from the monitor directly.

    Measured: Research period

  3. measurement of airway pressure variables from ventilator

    The investigators record the airway pressure variables during the inspiration and expiration from the ventilator

    Measured: 1 day

  4. P 0.1

    airway occlusion pressure at 100 milliseconds after the onset of inspiration (P0.1)(cmH2O)

    Measured: 1 day

  5. Pocc

    delta change of airway pressure during expiratory occlusion in different interventions.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2021
  2. Study start20 Mar 2021
  3. Primary completion30 Mar 2022
  4. Study completion30 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
189 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04802668
Sponsor's protocol ID
20210101PPV
Acronym
FacPPV
Status last verified
Jan 2023
First submitted
6 Feb 2021
Last updated
10 Jan 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Chen H, Liang M, He Y, Teboul JL, Sun Q, Xie J, Yang Y, Qiu H, Liu L. Inspiratory effort impacts the accuracy of pulse pressure variations for fluid responsiveness prediction in mechanically ventilated patients with spontaneous breathing activity: a prospective cohort study. Ann Intensive Care. 2023 Aug 17;13(1):72. doi: 10.1186/s13613-023-01167-0.

    PubMed 37592166

Questions about this trial

What is this clinical trial studying?

An observational study of Haemodynamics and Fluid Responsiveness, run by Southeast University, China at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

cardiac output(CO) (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04802668, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in